Biotricity Statistics
Total Valuation
Biotricity has a market cap or net worth of 10.38 million. The enterprise value is 37.43 million.
Market Cap | 10.38M |
Enterprise Value | 37.43M |
Important Dates
The next estimated earnings date is Friday, June 27, 2025.
Earnings Date | Jun 27, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Biotricity has 24.91 million shares outstanding. The number of shares has increased by 96.22% in one year.
Current Share Class | n/a |
Shares Outstanding | 24.91M |
Shares Change (YoY) | +96.22% |
Shares Change (QoQ) | +7.73% |
Owned by Insiders (%) | 29.62% |
Owned by Institutions (%) | n/a |
Float | 17.28M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.54 |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -2.61 |
EV / Sales | 2.82 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.23
Current Ratio | 0.23 |
Quick Ratio | 0.16 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -0.83 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -50.53% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 30.60% |
Revenue Per Employee | 241,200 |
Profits Per Employee | -260,363 |
Employee Count | 55 |
Asset Turnover | 2.31 |
Inventory Turnover | 1.88 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.35% in the last 52 weeks. The beta is 1.33, so Biotricity's price volatility has been higher than the market average.
Beta (5Y) | 1.33 |
52-Week Price Change | -69.35% |
50-Day Moving Average | 0.47 |
200-Day Moving Average | 0.47 |
Relative Strength Index (RSI) | 44.67 |
Average Volume (20 Days) | 25,998 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 2.88 |
Income Statement
In the last 12 months, Biotricity had revenue of 13.27 million and -14.32 million in losses. Loss per share was -0.83.
Revenue | 13.27M |
Gross Profit | 9.86M |
Operating Income | -4.64M |
Pretax Income | -10.67M |
Net Income | -14.32M |
EBITDA | -4.63M |
EBIT | -4.64M |
Loss Per Share | -0.83 |
Balance Sheet
The company has 2.06 million in cash and 25.46 million in debt, giving a net cash position of -23.40 million or -0.94 per share.
Cash & Cash Equivalents | 2.06M |
Total Debt | 25.46M |
Net Cash | -23.40M |
Net Cash Per Share | -0.94 |
Equity (Book Value) | -28.29M |
Book Value Per Share | -1.30 |
Working Capital | -16.28M |
Cash Flow
Operating Cash Flow | -3.15M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 74.31%, with operating and profit margins of -34.96% and -80.42%.
Gross Margin | 74.31% |
Operating Margin | -34.96% |
Pretax Margin | -80.42% |
Profit Margin | -80.42% |
EBITDA Margin | -34.92% |
EBIT Margin | -34.96% |
FCF Margin | n/a |
Dividends & Yields
Biotricity does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -96.22% |
Shareholder Yield | -96.22% |
Earnings Yield | -137.91% |
FCF Yield | n/a |
Stock Splits
The last stock split was on July 3, 2023. It was a reverse split with a ratio of 0.1666667.
Last Split Date | Jul 3, 2023 |
Split Type | Reverse |
Split Ratio | 0.1666667 |
Scores
Biotricity has an Altman Z-Score of -35.54. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -35.54 |
Piotroski F-Score | n/a |